首页> 外文期刊>Molecular and Cellular Endocrinology >Interplay of ER alpha binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells
【24h】

Interplay of ER alpha binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells

机译:Intron-2中的ERα结合和DNA甲基化的相互作用决定了乳腺癌细胞中胱抑素A的表达和雌激素调节

获取原文
获取原文并翻译 | 示例
           

摘要

Despite advances in early detection and treatment, invasion and metastasis of breast tumors remains a major hurdle. Cystatin A (CSTA, also called stefin A), an estrogen-regulated gene in breast cancer cells, is an inhibitor of cysteine cathepsins, and a purported tumor suppressor. Loss of CSTA expression in breast tumors evidently shifts the balance in favor of cysteine cathepsins, thereby promoting extracellular matrix remodeling, tumor invasion and metastasis. However, the underlying mechanism behind the loss of CSTA expression in breast tumors is not known. Here, we have analyzed CSTA expression, and methylation of upstream and intron-2 CpG sites within the CSTA locus in human breast cancer cell lines and breast tumors of the TCGA cohort. Results showed an inverse relationship between expression and methylation. Sequence analysis revealed a potential estrogen response element (ERE) in the intron-2. Analysis of ChIP-seq data (ERP000380) and our own ChIP experiments showed that 17 beta-estradiol (E2) enhanced ER alpha binding to this ERE in MCF-7 cells. This ERE was located amidst the differentially methylated intron-2 CpG sites, which provoked us to examine the possible conflict between estrogen-regulation of CSTA and DNA methylation in the intron-2. We analyzed the expression of CSTA and its regulation by E2 in MDA-MB-231 and T47D cells subjected to global demethylation by 5-azacytidine (5-aza). 5-aza significantly demethylated intron-2 CpGs, and enhanced estrogen-induced ER alpha occupancy at the intron-2 ERE, leading to restoration of estrogen-regulation. Taken together, our results indicate that DNA methylation-dependent silencing could play a significant role in the loss of CSTA expression in breast tumors. The potential of DNA methylation as an indicator of CSTA expression or as a marker of tumor progression can be explored in future investigations. Furthermore, our results indicate the convergence of ER alpha-mediated estrogen regulation and DNA methylation in the intron-2, thereby offering a novel context to understand the role of estrogen-ER alpha signaling axis in breast tumor invasion and metastasis.
机译:尽管早期检测和治疗进展,但乳腺肿瘤的侵袭和转移仍然是一个主要的障碍。胱抑素A(CSTA,也称为斯柯逊A),乳腺癌细胞中的雌激素调节基因,是半胱氨酸组织蛋白的抑制剂,以及据称的肿瘤抑制剂。乳腺肿瘤中CSTA表达的丧失明显地改变了半胱氨酸组织蛋白的平衡,从而促进细胞外基质重塑,肿瘤侵袭和转移。然而,乳腺肿瘤中丧失CSTA表达背后的潜在机制尚不清楚。在这里,我们在人乳腺癌细胞系和TCGA队列的乳腺肿瘤中分析了CSTA表达和甲基化上游和内含子-2 CPG位点的甲基化。结果表明表达与甲基化之间的反比关系。序列分析显示Intron-2中的潜在雌激素反应元件(ORE)。芯片-SEQ数据(ERP000380)和我们自己的芯片实验的分析表明,17β-雌二醇(E2)增强了在MCF-7细胞中对该IRE的ERα结合。在差异甲基化的内含子 - 2个CPG位点中,这种IRE位于偶然的甲基化的内含子网站,这激起了美国,检查CSTA和Intron-2中的DNA甲基化之间的可能突出。我们分析了通过5-氮杂胞苷(5-AZA)对全球去甲基化的MDA-MB-231和T47D细胞中E2的表达及其调节。 5-AZA显着去甲基化内含子 - 2个CPG,并增强了Intron-2 ere的雌激素诱导的ERα占患者,导致雌激素调节恢复。我们的结果表明,DNA甲基化依赖性沉默可能在乳腺肿瘤中丧失CSTA表达的丧失中起重要作用。可以探讨DNA甲基化作为CSTA表达的指示剂或作为肿瘤进展标记的潜力,以便在未来的调查中可以探讨。此外,我们的结果表明,Intron-2中的ERα介导的雌激素调节和DNA甲基化的收敛,从而提供了一种新的背景,以了解雌激素-ERα信号轴在乳腺肿瘤侵袭和转移中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号